Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Mouritzen

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Pain|January 25, 2021
A genome-wide screen reveals microRNAs in peripheral sensory neurons driving painful diabetic neuropathyKiran Kumar Bali, Jagadeesh Gandla, Daniel Rojas Rangel, et al.
Diagnostics (Basel, Switzerland)|April 2, 2020
Profiling of Circulating microRNAs in Prostate Cancer Reveals Diagnostic Biomarker PotentialJacob Fredsøe, Anne K I Rasmussen, Peter Mouritzen, et al.
Oncotarget|April 28, 2016
Novel diagnostic and prognostic classifiers for prostate cancer identified by genome-wide microRNA profilingHelle Kristensen, Anni R Thomsen, Christa Haldrup, et al.
European Urology Focus|July 30, 2017
Diagnostic and Prognostic MicroRNA Biomarkers for Prostate Cancer in Cell-free UrineJacob Fredsøe, Anne K I Rasmussen, Anni R Thomsen, et al.
International Journal of Cancer|May 25, 2019
A novel combined miRNA and methylation marker panel (miMe) for prediction of prostate cancer outcome after radical prostatectomySiri H Strand, Elham Bavafaye-Haghighi, Helle Kristensen, et al.
Clinical Chemistry|February 8, 2019
Independent Validation of a Diagnostic Noninvasive 3-MicroRNA Ratio Model (<i>uCaP</i>) for Prostate Cancer in Cell-Free UrineJacob Fredsøe, Anne K I Rasmussen, Emma B Laursen, et al.
The Journal of Clinical Endocrinology and Metabolism|March 31, 2005
Analysis of separate and combined effects of common variation in KCNJ11 and PPARG on risk of type 2 diabetesSara K Hansen, Eva-Maria D Nielsen, Jakob Ek, et al.
Methods (San Diego, Calif.)|February 14, 2021
Verification of CRISPR editing and finding transgenic inserts by Xdrop indirect sequence capture followed by short- and long-read sequencingThorarinn Blondal, Cristina Gamba, Lea Møller Jagd, et al.
International Journal of Molecular Sciences|March 15, 2019
Aberrant <i>DOCK2</i>, <i>GRASP</i>, <i>HIF3A</i> and <i>PKFP</i> Hypermethylation has Potential as a Prognostic Biomarker for Prostate CancerMarianne T Bjerre, Siri H Strand, Maibritt Nørgaard, et al.
Frontiers in Molecular Neuroscience|October 24, 2013
microRNAs in nociceptive circuits as predictors of future clinical applicationsMichaela Kress, Alexander Hüttenhofer, Marc Landry, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Pain|January 25, 2021
A genome-wide screen reveals microRNAs in peripheral sensory neurons driving painful diabetic neuropathyKiran Kumar Bali, Jagadeesh Gandla, Daniel Rojas Rangel, et al.
Diagnostics (Basel, Switzerland)|April 2, 2020
Profiling of Circulating microRNAs in Prostate Cancer Reveals Diagnostic Biomarker PotentialJacob Fredsøe, Anne K I Rasmussen, Peter Mouritzen, et al.
Oncotarget|April 28, 2016
Novel diagnostic and prognostic classifiers for prostate cancer identified by genome-wide microRNA profilingHelle Kristensen, Anni R Thomsen, Christa Haldrup, et al.
European Urology Focus|July 30, 2017
Diagnostic and Prognostic MicroRNA Biomarkers for Prostate Cancer in Cell-free UrineJacob Fredsøe, Anne K I Rasmussen, Anni R Thomsen, et al.
International Journal of Cancer|May 25, 2019
A novel combined miRNA and methylation marker panel (miMe) for prediction of prostate cancer outcome after radical prostatectomySiri H Strand, Elham Bavafaye-Haghighi, Helle Kristensen, et al.
Clinical Chemistry|February 8, 2019
Independent Validation of a Diagnostic Noninvasive 3-MicroRNA Ratio Model (<i>uCaP</i>) for Prostate Cancer in Cell-Free UrineJacob Fredsøe, Anne K I Rasmussen, Emma B Laursen, et al.
The Journal of Clinical Endocrinology and Metabolism|March 31, 2005
Analysis of separate and combined effects of common variation in KCNJ11 and PPARG on risk of type 2 diabetesSara K Hansen, Eva-Maria D Nielsen, Jakob Ek, et al.
Methods (San Diego, Calif.)|February 14, 2021
Verification of CRISPR editing and finding transgenic inserts by Xdrop indirect sequence capture followed by short- and long-read sequencingThorarinn Blondal, Cristina Gamba, Lea Møller Jagd, et al.
International Journal of Molecular Sciences|March 15, 2019
Aberrant <i>DOCK2</i>, <i>GRASP</i>, <i>HIF3A</i> and <i>PKFP</i> Hypermethylation has Potential as a Prognostic Biomarker for Prostate CancerMarianne T Bjerre, Siri H Strand, Maibritt Nørgaard, et al.
Frontiers in Molecular Neuroscience|October 24, 2013
microRNAs in nociceptive circuits as predictors of future clinical applicationsMichaela Kress, Alexander Hüttenhofer, Marc Landry, et al.
Pageof 4